The rapid emergence of resistant bacteria is occurring worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives.  Many decades after the first patients were treated with antibiotics, bacterial infections have again become a threat.

The current antibiotic resistance crisis has been attributed to the overuse and misuse of antibiotics. The CDC and other organizations and experts recommend improving microbial identification and optimizing therapeutic regimens, among other actions, to combat the current crisis.

These findings highlight the need for pathogen identification and antibiotic resistance characterization in treatment selection for infectious disease. 

ATA has partnered with leading clinical laboratories to provide a comprehensive solution to infectious disease management. State of the art molecular diagnostics allow for rapid microbial pathogen identification and detection of antimicrobial resistance. You can have these results normally back 24-48 hours from time received.

Pathogen characterization panels provide comprehensive and specific pathogen information for the following types of infections: Respiratory, UTI, STI, Wound, and Gastrointestinal. ATA’s PharmDs interpret these diagnostics and uses the genetic microbial characterization to provide antibiotic therapy recommendations based on the microbial species and resistance. The therapeutic recommendations are then provided with the PCR report to the ordering physician.

ATA’s Therapeutic Guidance Reports delivers  a comprehensive antimicrobial stewardship report that is patient specific just for you.